🇺🇸 FDA
Pipeline program

MRx0518 Capsules

C/35/2017

Phase 1 small_molecule active

Quick answer

MRx0518 Capsules for Melanoma is a Phase 1 program (small_molecule) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
4D Molecular Therapeutics
Indication
Melanoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials